Automating Knowledge Discovery
The FUSION Analytics Platform™ is a high-performance cognitive computing system for academic and commercial scientists to create effective bench-level discovery operations at the desktop. FUSION provides multi-scale data management, high-performance computing on-demand, and automated model development, quality assessment, and interactive sharing all from our award-winning dashboard. Contact our team of Solutions Engineers to learn how embedding FUSION’s advanced analytics into new or existing applications and workflows can accelerate discovery and drive advanced research initiatives. At IOMICS, we believe in the power of analytics to change our world.
FUSION for Chemical Engineering
The pace and complexity of chemical engineering is rapidly increasing. To maintain progress, the industry must embrace new tools and new methodologies capable of extracting meaning from a broad range of chemical and molecular data sets. The FUSION Analytics Platform™ can utilize multiple high quality data types to model and characterize chemical and environmental activity, and to predict potential toxicity or other behaviors of interest in new compounds.
FUSION can be live linked with chemical assays, production instrumentation, and environmental sensors, which enables a new class of real-time analysis and control. This permits identification of hidden chemical hazards, promotes safer production processes, and accelerates new product research. The computational strategies utilized within the FUSION Analytics Platform can guide green chemical design, safer food production, and more effective bioremediation practices.
Chemical Intelligence. We can make it happen for you.™
Chemical engineers can now rapidly build and validate models to test compound response hypotheses in silico. The FUSION Analytics Platform permits rapid data set staging, in silico based chemical analysis, and real-time model sharing and collaboration with team members from around the world.
FUSION for Medical Research
The pace and complexity of medical research is rapidly increasing. The industry has become data rich, yet obtaining actionable knowledge remains a challenge. To maintain progress, the industry must embrace new tools and new methodologies capable of extracting meaning from a broad range of chemical and molecular data sets. The FUSION Analytics Platform™ can utilize multiple high quality data types to model and characterize highly dynamic molecular processes and cellular activity.
FUSION can be live linked with NGS technologies, high complexity assays, and digital instrumentation, which enables a new class of real-time analysis. This accelerates the identification of druggable properties and drives fragment-based drug discovery, scaffold design, and ADME/tox prediction. The computational strategies utilized within the FUSION Analytics Platform can help provide critical new insights about whether you have the right target, the right exposure, the right drug.
Molecular Intelligence. We can make it happen for you.™
Chemists and biologists can rapidly build and validate models to test compound response hypotheses in silico. FUSION cuts complex model development time from months to days allowing you to profile molecular behavior in novel ways. FUSION models permit rapid in silico based analysis, encourages real-time collaboration among domain experts, and even allows you to cloud-deploy predictive models to other team members around the world with just a few keystrokes.
FUSION for Clinical Care
The pace and complexity of healthcare is rapidly increasing. Medicine has now entered its data age with context-sensitive EHR/HIE systems, high-complexity assays, wearable body sensors, mobile technologies and telemedicine, and a broad range of online patient/caregiver forums and information resources. As a result, it is now possible to capture vast amounts of information about our individual and shared biology as well as the environment around us. The sum of this information will transform medicine, turning a field aimed at treating the average patient into one that will soon customize treatment to the individual.
To cost-effectively develop and deploy personalized medicine strategies and new wellness programs, we need more powerful analytics capable of extracting important signals within high-complexity assays and across multiple data types. The FUSION Analytics Platform™ is designed to stratify patient populations and extract actionable information for clinical use within high-fidelity point-of-care models. Healthcare workers can use deployed FUSION models to improve patient outcomes, reduce costs, and forge stronger value-added linkages between the institution and the patient.
Clinical Intelligence. We can make it happen for you.™
Healthcare workers can now rapidly build and validate patient and disease models to test intervention effectiveness both in silico and in the clinic. FUSION cuts complex patient model development time from months to weeks allowing you to profile patient, disease, and drug behavior in novel ways. FUSION models will permit rapid in silico based patient profiling and intervention prioritization to support real-time coordinated care between institutions, healthcare workers, patients, and caregivers.
ASPEN™ is a feature-rich in silico model building and hypothesis discovery service that allows you to perform real-time specification-based data staging and predictive model development for a broad range of chemical characterization, biomarker discovery, and drug development initiatives. ASPEN is the only solution that seamlessly combines chemical and molecular data staging, predictive model creation, validation, and performance reporting, along with realtime pathway analysis and automated evidence summaries, all in one integrated service. ASPEN users can start the accelerated discovery process by querying our semantically integrated knowledgebase with contents from hundreds of open access chemical and molecular sources, or by using IOMICS SmartETL™ technology to rapidly upload experimental data and results from your laboratory direct to ASPEN’s private and secure virtual machine environment. For high-throughput experiments, ASPEN also provides options for linking with NGS technologies, high-complexity assays, and digital instrumentation for both automated and continuous analysis and process characterization. ASPEN is accelerating scientific discovery by eliminating the major scientific and operational barriers to developing and using high-quality data-driven computational models in your research.
